GoldenBiotech Antroquinonol Phase 2 NSCLC Clinical Study Presents Brilliant Results in ASCO Meeting.


Golden Biotechnology Corp.’s Antroquinonol Phase 2 NSCLC Clinical Study Presents Advanced Results in ASCO Meeting Abstract....

Golden Biotechnology Corp. Starts Phase 2 Trial for Efficacy of Antroquinonol in AML after Russian MOH Approval


Golden Biotechnology Corp.(TW4132) received the Russian MoH approval letter on January 16, 2019 for the implementation in Russia to perform Phase 2 clinical trial of acute myeloid leukemia (AML)...



Antroquinonol® is the pure compound extracted from Antrodia camphorata. Antroquinonol® is patented by Golden Biotech and helps support the immune system.

We have finalized 10 new leading candidates for new drug development.

Antroquinonol® has applied for compound and use patents worldwide.